Santiago Pérez-Patrigeón

Preserved Central Memory and Activated Effector Memory CD4⁺T-Cell Subsets in Human Immunodeficiency Virus Controllers: an ANRS EP36 Study

Simon J. Potter, Christine Lacabaratz, Olivier Lambotte et al. · Journal of Virology · 2007 · 171 citations

Life Sciences, Immunology, Infectious Diseases +17

Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial

Richard T. Davey, Eduardo Fernández‐Cruz, Norman Markowitz et al. · The Lancet Respiratory Medicine · 2019 · 134 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +12

Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, randomised phase 2 trial

Yajing Bao, Joy Beeler, Weerawat Manosuthi et al. · The Lancet Infectious Diseases · 2017 · 99 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +10

HIV Controller CD4+ T Cells Respond to Minimal Amounts of Gag Antigen Due to High TCR Avidity

Benoît Vingert, Santiago Pérez-Patrigeón, Patricia Jeannin et al. · PLoS Pathogens · 2010 · 85 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

HIV Controllers Maintain a Population of Highly Efficient Th1 Effector Cells in Contrast to Patients Treated in the Long Term

Benoît Vingert, Daniela Benati, Olivier Lambotte et al. · Journal of Virology · 2012 · 68 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17